Stewart Parker is a biotech consultant and was previously the CEO of the Infectious Disease Research Institute in Seattle. Parker co-founded Seattle-based Targeted Genetics and worked there as president and CEO since it spun off from Immunex in 1992 until November 2008. She served in various capacities at Immunex from August 1981 through December 1991, most recently as vice president, corporate development. Ms. Parker also served as president and a director of Receptech Corporation, a company formed by Immunex in 1989 to accelerate the development of soluble cytokine receptor products, from February 1991 to January 1993. She serves on the board of directors and the executive committee of BIO, the primary trade organization for the biotechnology industry, and as a director of several companies and non-profit organizations. Ms. Parker received her B.A. and M.B.A. from the University of Washington.
[Editor’s Note: This editorial was co-authored by Jim Connolly, president and CEO of Rockville, MD-based Aeras]
Extensively drug-resistant tuberculosis (XDR-TB) is more prevalent than experts realized and continues to... Read more »
First of all, don’t be fainthearted. Let’s face it, the Michigan workforce has been trained to perform in very hierarchical institutions, where compliance is rewarded and innovation is not. The old... Read more »
For the last 17 years my office at Targeted Genetics looked out closely onto a pretty major intersection, busy with cars and pedestrians going to and from downtown Seattle. For years... Read more »
© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.